News tagged with cell immunity

Opdivo approval expanded to include lung cancer

(HealthDay)—U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small cell lung cancer (NSCLC), the agency said Wednesday in a news release.

Mar 04, 2015
popularity 2 comments 0

Team finds key to tuberculosis resistance

The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis ...

Mar 02, 2015
popularity 16 comments 0